Impact of co-morbidities in COVID -19 infected patients

Preeti, Verma, Sachin, Chaudhary, Samarjeet, Kaur, Tanu, Midha, Martolia, D. S.

Preeti, Verma, Sachin, Chaudhary, Samarjeet, Kaur, Tanu, Midha, Martolia, D. S..

Indian Journal of Community Health ; 34(1):26-29, 2022.

Article in English | CAB Abstracts | ID: covidwho-1836661

ABSTRACT

ABSTRACT

Background:

During the COVID- 19 pandemic in the first wave, infected patients age was range from 4 weeks to 90 years and those who have more age and with comorbidities are more susceptible to develop serious illness and have high mortality rates.

Keywords

Prion, Viral, Bacterial and Fungal Pathogens of Humans [VV210]; Non-communicable Human Diseases and Injuries [VV600]; human diseases; hypertension; risk factors; mortality; viral diseases; coronavirus disease 2019; comorbidity; patients; pandemics; symptoms; blood sugar; platelets; diabetes mellitus; chronic obstructive pulmonary disease; lungs; respiratory diseases; chronic diseases; blood pressure; survival; prognosis; Severe acute respiratory syndrome coronavirus 2; man; Uttar Pradesh; India; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Commonwealth of Nations; lower-middle income countries; medium Human Development Index countries; South Asia; Asia; SARS-CoV-2; high blood pressure; death rate; viral infections; blood glucose; glucose in blood; blood platelets; thrombocytes; lung diseases

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: CAB Abstracts Type of study: Experimental Studies Language: English Journal: Indian Journal of Community Health Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google